Nonalcoholic fatty liver disease is a term used to describe the accumulation of fat in the liver of people who drink little or no alcohol.
Nonalcoholic fatty liver disease is common and, for most people, causes no signs and symptoms and no complications.
But in some people with nonalcoholic fatty liver disease, the fat that accumulates can cause inflammation and scarring in the liver. This more serious form of nonalcoholic fatty liver disease is sometimes called nonalcoholic steatohepatitis.
At its most severe, nonalcoholic fatty liver disease can progress to liver failure.
Jan. 02, 2014
- Non-alcoholic fatty liver disease (NAFLD). American College of Gastroenterology. http://patients.gi.org/topics/fatty-liver-disease-nafld. Accessed Sept. 26, 2013.
- Non-alcoholic fatty liver disease. American Liver Foundation. http://www.liverfoundation.org/abouttheliver/info/nafld. Accessed Sept. 26, 2013.
- Feldman M, et al. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9th ed. Philadelphia, Pa.: Saunders Elsevier; 2010. http://www.clinicalkey.com. Accessed Sept. 26, 2013.
- Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases and American College of Gastroenterology. Gastroenterology. 2012;142:1592.
- Molloy JW, et al. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis and degree of hepatic fibrosis. Hepatology. 2012;55:429.
- Golden AK. Decision Support System. Mayo Clinic, Rochester, Minn. Aug. 16, 2013.
- Ludwig J, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings. 1980;55:434
- Venkatesh SK, et al. Magnetic resonance elastography of liver: Technique, analysis and clinical applications. Journal of Magnetic Resonance Imaging. 2013;37:544.
- ACIP Adult Immunization Work Group. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older — United States, 2013. MMWR. 2013;62:13. http://www.cdc.gov/mmwr/preview/mmwrhtml/su6201a3.htm?s_cid=su6201a3_w. Accessed Oct. 11, 2013.